Results

Total Results: 744 records

Showing results for "presence".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_executive.pdf
    February 01, 2013 - During evaluation of the presence/extent of CAD and the potential necessity of coronary intervention … During evaluation of the presence/extent of CAD and the potential need for coronary intervention? … Even though presence of distal left main disease was significantly associated with adverse outcomes
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
    August 16, 2016 - value of these non-invasive imaging techniques depend on operator's experience, body habitus, the presence … are contraindicated in patients with renal insufficiency, and both studies are compromised by the presence … alone in patients who truly have a high degree of stenosis >80% (see discussion below) and/or in the presence
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
    December 08, 2014 - Extensive stage disease (ED): Cancer that cannot be classified as limited stage, such as when there is presence … patients cannot receive iodinated contrast material due to renal insufficiency, limiting evaluation for presence … This will be addressed by noting the presence of abstracts or ClinicalTrials.gov entries describing
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
    June 01, 2012 - missing Or include, but: Flag missing elements in tables/text Organize data within key questions by presence … /absence of key elements Include presence/ absence as parameter in meta-regression or sensitivity analyses … The presence or absence of the parameter may be considered in a meta-regression or sensitivity analysis
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - salpingo-oophorectomy) has been used in women who are at a high risk of developing ovarian cancer due to the presence … individual women, accounting for the potential influence of other factors, such as timing of OC use or presence … Additionally, when appropriate, the studies were evaluated for dose-response association, the presence
  6. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
    June 01, 2012 - missing Or include, but: Flag missing elements in tables/text Organize data within key questions by presence … /absence of key elements Include presence/ absence as parameter in meta-regression or sensitivity analyses … The presence or absence of the parameter may be considered in a meta-regression or sensitivity analysis
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
    December 23, 2014 - evaluation approaches for treatment planning • Other imaging modalities Outcomes • Ability to identify presence … angiography § Echocardiography § Ultrasonography § Endoscopy Outcomes Ability to identify presence … clinic, otolaryngology clinics, dermatology clinics, pediatric surgical unit) • Ability to identify presence
  8. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
    March 01, 2022 - for a given primary substance of misuse, severity of use, and how effectiveness is moderated by the presence … Interventions • Studies to understand how underlying pain mechanisms, presence of specific pain conditions … (e.g., autoimmune, congenital, sickle cell) and presence of genetic polymorphisms affecting opioid
  9. S77 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s77.pdf
    October 01, 2007 - Based on the lack of an annual premium and deductible at the VA, and the presence of the donut hole in
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol-amendment.pdf
    February 04, 2025 - The presence of information about barriers and facilitators in quantitative studies will be identified … magnitude of effects identified in included studies, possible selective outcome reporting, and noting the presence
  11. effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
    January 01, 2013 - The presence or absence of statistical interaction depends on various mathematical aspects of the regression
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
    December 09, 2009 - approach incorporates the following elements: study design, study quality, consistency, directness, presence
  13. S108 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s108.pdf
    October 01, 2007 - Regardless of the presence or absence of confounding and whether the confounding was baseline or time-varying … Our simulation highlights the discrepancy between population and individual effects in the presence of
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - fair NR/NR/379 Previous participation in meloxicam trial; clinical evidence of peptic ulceration; presence … Recent treatment with disease-modifying drugs, oral corticosteroids or corticosteroid injections; presence … /no/no no unclear for efficacy; yes for safety Laine method NR allocation stratified by the presence … Control group standar d of care Funding Geusens 2002 yes (n=35) fair/poor 1344/NR/10 23 Presence … No significant interaction with age, gender, or presence of risk factors Graham 2005State
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
    February 01, 2012 - Assay—An analysis conducted to verify the presence (and amount) of a substance. … changes in the DNA sequence. 7 Guaiac based fecal occult blood test (FOBT)—An assay to detect the presence … Immunochemical based fecal occult blood test (FOBT) or fecal immunochemical test (FIT)—An assay to detect the presence
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
    December 27, 2016 - A Cochrane p-value of <0.10 suggests the presence of statistical heterogeneity. … To assess for the presence of publication bias, visual inspection of funnel plots will be considered
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
    March 29, 2011 - essential diagnostic features of disorders on the ASD spectrum as follows: o Autism: “…[T]he presence … interaction associated with impairment in either verbal or nonverbal communication skills or with the presence
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
    November 01, 2017 - Studies were rated as “low risk of bias,” “medium risk of bias,” or “high risk of bias” based on the presence … of opioid involved in overdose (including whether fentanyl or a fentanyl analogue was involved), presence
  19. S58 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s58.pdf
    October 01, 2007 - data use and validity checking, approaches to statistical modeling of longitudinal patterns in the presence … Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
    March 13, 2012 - Different subpopulations of women (e.g., based on age, family history, the presence of BRCA1/BRCA2 mutations … Additionally, when appropriate, the studies will be evaluated for dose-response association, the presence

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: